These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hepatic gene therapy using adeno-associated virus vectors. Patijn GA; Kay MA Semin Liver Dis; 1999; 19(1):61-9. PubMed ID: 10349684 [TBL] [Abstract][Full Text] [Related]
4. [Gene therapy in liver diseases using adeno-associated virus as a vector]. You H; Jia JD; Wang BE Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):639-40. PubMed ID: 16093007 [No Abstract] [Full Text] [Related]
5. Genetic-Based Approaches to Inherited Metabolic Liver Diseases. Zabaleta N; Hommel M; Salas D; Gonzalez-Aseguinolaza G Hum Gene Ther; 2019 Oct; 30(10):1190-1203. PubMed ID: 31347416 [TBL] [Abstract][Full Text] [Related]
7. AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application? van der Laan LJ; Wang Y; Tilanus HW; Janssen HL; Pan Q Expert Opin Biol Ther; 2011 Mar; 11(3):315-27. PubMed ID: 21204741 [TBL] [Abstract][Full Text] [Related]
8. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system. Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400 [TBL] [Abstract][Full Text] [Related]
9. Potential of AAV vectors in the treatment of metabolic disease. Alexander IE; Cunningham SC; Logan GJ; Christodoulou J Gene Ther; 2008 Jun; 15(11):831-9. PubMed ID: 18401432 [TBL] [Abstract][Full Text] [Related]
11. The adeno-associated virus vector for orthopaedic gene therapy. Schwarz EM Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S31-9. PubMed ID: 11039749 [TBL] [Abstract][Full Text] [Related]
12. [Construction of a recombinant adeno-associated virus hybrid vectors with the HBV capsid for gene therapy of liver diseases]. Zhang MM; Gou XH; Li DH; Guo CB; Tang D; Kang Q; Han L; Zhao LY; Hu HY Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):707-8. PubMed ID: 19785966 [No Abstract] [Full Text] [Related]
13. Progress in the use of adeno-associated viral vectors for gene therapy. Büning H; Braun-Falco M; Hallek M Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988 [TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism. Lagor WR; Johnston JC; Lock M; Vandenberghe LH; Rader DJ Methods Mol Biol; 2013; 1027():273-307. PubMed ID: 23912992 [TBL] [Abstract][Full Text] [Related]
15. Current Status on Clinical Development of Adeno-Associated Virus-Mediated Liver-Directed Gene Therapy for Inborn Errors of Metabolism. Ginocchio VM; Ferla R; Auricchio A; Brunetti-Pierri N Hum Gene Ther; 2019 Oct; 30(10):1204-1210. PubMed ID: 31517544 [TBL] [Abstract][Full Text] [Related]
16. AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia. Cunningham SC; Kok CY; Spinoulas A; Carpenter KH; Alexander IE Gene Ther; 2013 Dec; 20(12):1184-7. PubMed ID: 24108150 [TBL] [Abstract][Full Text] [Related]